Global Regulation of Human Genome Editing: Legal and Ethical Dilemmas

This research paper takes a closer look at how different countries around the world are dealing with human genome editing, a fast-growing area in science and medicine. Genome editing, especially with tools like CRISPR-Cas9, has the potential to treat genetic diseases, improve human health, and even alter future generations. However, it also brings many serious questions about safety, ethics, and fairness. The paper compares how various countries have created different laws and policies to regulate this technology. Some countries have strict rules that completely ban editing human embryos, while others allow it under certain conditions. These differences show a lack of global agreement, which can lead to confusion and potential misuse of the technology. In addition to national laws, the paper also explores the role of international organizations such as the World Health Organization (WHO) and UNESCO. These bodies have called for the responsible use of genome editing and have suggested the need for global guidelines. Yet, there is still no single international law that all countries follow. The paper also discusses major ethical issues, such as editing genes in embryos, which can pass changes to future generations. This raises concerns about consent, inequality, and the possibility of creating “designer babies.” There are also fears that powerful countries or companies could misuse this technology for profit or control. Because of these challenges, the paper argues that the world needs a more united approach. It calls for creating shared legal standards and strong ethical review systems to ensure genome editing is used safely, fairly, and in ways that respect human rights. It also highlights the importance of public awareness and global cooperation to guide the future of genome editing in a responsible direction.